Evidence map›Paper›PMID 29898395›Full record

ArticleCell reports2018

POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression.

Bjorg Gudmundsdottir, Kristbjorn O Gudmundsson, Kimberly D Klarmann, Satyendra K Singh, Lei Sun, Shweta Singh, Yang Du, Vincenzo Coppola, Luke Stockwin, Nhu Nguyen and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. CRISPR-engineered deletion ofbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Deficiency ofBrain communications · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 2 countries.

Bjorg GudmundsdottirMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/12-70, 1050 Boyles Street, Frederick, MD 21702, USA.
Kristbjorn O GudmundssonMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/12-70, 1050 Boyles Street, Frederick, MD 21702, USA.
Kimberly D KlarmannMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/12-70, 1050 Boyles Street, Frederick, MD 21702, USA; Basic Research Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bldg. 560/32-31D, 1050 Boyles Street, Frederick, MD 21702, USA.
Satyendra K SinghMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/12-70, 1050 Boyles Street, Frederick, MD 21702, USA.
Lei SunMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/12-70, 1050 Boyles Street, Frederick, MD 21702, USA.
Shweta SinghMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/12-70, 1050 Boyles Street, Frederick, MD 21702, USA.
Yang DuDepartment of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
Vincenzo CoppolaWexner Medical Center, Ohio State University, 460 West 12(th)Avenue, Columbus, OH 43210, USA.
Luke StockwinDrug Mechanisms Group, Developmental Therapeutics Program, Leidos Biomedical Research, Inc., National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Nhu NguyenDepartment of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
Lino TessarolloMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/12-70, 1050 Boyles Street, Frederick, MD 21702, USA.
Leifur ThorsteinssonThe Blood Bank, Landspitali University Hospital, Snorrabraut 60, 105 Reykjavik, Iceland.
Olafur E SigurjonssonThe Blood Bank, Landspitali University Hospital, Snorrabraut 60, 105 Reykjavik, Iceland.
Sveinn GudmundssonThe Blood Bank, Landspitali University Hospital, Snorrabraut 60, 105 Reykjavik, Iceland.
Thorunn RafnarIceland Genomics Corporation, Snorrabraut 60, 105 Reykjavik, Iceland.
John F TisdaleMolecular and Clinical Hematology Branch, NHLBI/NIDDK, NIH, Bethesda, MD 20814, USA.
Jonathan R KellerMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, Bldg. 560/12-70, 1050 Boyles Street, Frederick, MD 21702, USA; Basic Research Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Bldg. 560/32-31D, 1050 Boyles Street, Frederick, MD 21702, USA. Electronic address: kellerjo@mail.nih.gov.
Center for Cancer Research · USNational University Hospital of Iceland · ISNational Cancer Institute · USUniformed Services University of the Health Sciences · USFrederick National Laboratory for Cancer Research · USLeidos (United States) · USNational Heart Lung and Blood Institute · USThe Ohio State University Wexner Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
CCR-Frederick Flow Cytometry CoreZICBC011236 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CARRELL, JEFFREY · 2009 to 2025
$11.5M
Gene Targeting FacilityZICBC011265 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TESSAROLLO, LINO · 2010 to 2025
$8.9M
Isolation, characterization, and transplantation of candidate stem cellsZ01HL006009 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI TISDALE, JOHN · 2008 to 2008
$220k
CCR NIH HHS HHSN261200800001CIntramural NIH HHS Z01 HL006009NCI NIH HHS HHSN261200800001ENCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

Fetal globin genes are transcriptionally silenced during embryogenesis through hemoglobin switching. Strategies to derepress fetal globin expression in the adult could alleviate symptoms in sickle cell disease and β-thalassemia. We identified a zinc-finger protein, pogo transposable element with zinc-finger domain (POGZ), expressed in hematopoietic progenitor cells. Targeted deletion of Pogz in adult hematopoietic cells in vivo results in persistence of embryonic β-like globin expression without affecting erythroid development. POGZ binds to the Bcl11a promoter and erythroid-specific intragenic regulatory regions. Pogz

Indexed as

Animalsbeta-GlobinsCarrier ProteinsCell DifferentiationEmbryo, MammalianEmbryonic DevelopmentErythroblastsFetal HemoglobinHematopoietic Stem CellsHumansMiceMice, Inbred C57BLMice, KnockoutNuclear ProteinsPromoter Regions, GeneticRepressor ProteinsBCL11A protein, humanbeta-GlobinsCarrier ProteinsFetal HemoglobinNuclear ProteinsRepressor ProteinsRNA, Small InterferingTransposaseserythropoiesisfetal globingene regulationglobin switchinghematopoietic developmentred cellssickle cell diseasetranscriptionβ-thalassemia

Identifiers

PMID29898395
PMCPMC7301966
OpenAlexW2808024423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.